Full text is available at the source.
Abstract
Cardiovascular effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) may vary with age.
- Younger individuals may experience different cardiovascular responses to GLP-1RAs compared to older adults.
- The study evaluates age-related variations in cardiovascular effects associated with GLP-1RAs.
- Preliminary findings suggest a potential age-dependent relationship in the efficacy of GLP-1RAs.
- Further research is needed to clarify how age influences the cardiovascular impact of these medications.
Simplified